ZyMōt Fertility, Inc. news

DxNow, Inc., a privately held medical device company, announces receipt of FDA 510(k) clearance of its ZyMot™ ICSI and ZyMot™ Multi Sperm Separation Devices. DxNow is developing novel devices for use in assisted reproductive technology (ART) procedures conducted by fertility clinics and OB/GYN practices. The ZyMot devices are intended for preparing motile sperm from semen for use in the treatment of infertile couples by intracytoplasmic sperm injection (ICSI), intrauterine insemin